// App-Quantinova.ai

TCT-329 : Prospective Evaluation of Drug Eluting Self Apposing Stent for the Treatment of Unprotected Left Main Coronary Artery Disease: 1-Year Results of the TRUNC Study

Researchers

Presenter

  • Corrado Tamburino

Principal Investigators

  • Carlo Briguori

  • Gillian A. Jessurun

  • Krzysztof Reczuch

  • Bernardo Cortese

  • Luc Maillard

  • Andrzej Ochala

  • Floris Kauer

  • Marcus Siry

  • Gennaro Sardella

  • Adam Sukiennik

  • Alexander Ijsselmuiden

  • David Bouchez

  • Andreas Baumbach

Medical Centers

  • Albert Schweitzer Ziekenhuis, Dordrecht, Netherlands

  • Treant Zorggroep, Emmen, Netherlands

  • Ferrarotto Hospital, Cardiology Division, University of Catania, Catania, Italy

  • San Carlo Clinic, Milano, Milan, Italy

  • Amphia hospital- Medical center Breda, Breda LX, Netherlands

  • Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland

  • Department of Cardiology, Medical University of Wrocław, Wroclaw, Poland

  • GCS ES Axium Rambot, Aix en Provence, France

  • Klinikum Memmingen, Memmigen, Germany

  • Stentys, Paris, France

  • Policlinico Umberto I University, Rome, Italy

  • Clinica Mediterranea, Naples, Naples, Italy

  • Department of Cardiology Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland

  • Barts Heart Centre, London, United Kingdom

Locations

  • Netherlands

  • Poland

  • Italy

  • France

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left main disease

  • Myocardial infarction

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved